Cart (0 Items)
Your cart is currently empty.
View ProductsFutuximab Biosimilar – Anti-EGFR domain III , ERBB1 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Futuximab Biosimilar - Anti-EGFR domain III , ERBB1 mAb - Research Grade |
|---|---|
| Source | CAS 1310460-85-5 |
| Species | Chimeric |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Futuximab,DS 992,Sym 004 (combination of modotuximab and futuximab),EGFR domain III , ERBB1,anti-EGFR domain III , ERBB1 |
| Reference | PX-TA1293 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Futuximab Biosimilar - Anti-EGFR domain III , ERBB1 mAb - Research Grade
General information on Anti-EGFR domain III /ERBB1[Homo sapiens] (Futuximab) Monoclonal Antibody
Futuximab is investigated for the treatment of Solid Tumors.
Related products
Antigen
EGFR protein – Epidermal growth factor receptor(EGFR)
PX-P4586 210€
Antigen
Epidermal growth factor receptor(EGFR)
PX-P4657 210€
Antigen
EGFR / ERBB1 / HER1, C-His, recombinant protein
PX-P5701 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.